Equinox Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 36

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

Equinox General Information

Description

Developer of glaucoma treatment technology designed to treat diseases of the optic nerve. The company's technology uses an adjustable, non-surgical, non-pharmacological system that utilizes the natural laws of physics to balance pressures in and around the eye, enabling doctors to understand glaucoma based on a deep exploration of the physics of eye pressure.

Contact Information

Formerly Known As
EqualEyes
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2424 South East Bristol Street
  • Suite 250
  • Newport Beach, CA 92660
  • United States
+1 (949)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 2424 South East Bristol Street
  • Suite 250
  • Newport Beach, CA 92660
  • United States
+1 (949)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Equinox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Generating Revenue
5. Later Stage VC 05-Sep-2019 Completed Generating Revenue
4. Early Stage VC (Series B) 03-Mar-2018 Completed Generating Revenue
3. Seed Round 19-Dec-2017 Completed Generating Revenue
2. Grant 01-Mar-2015 Completed Generating Revenue
1. Angel (individual) Completed Startup
To view Equinox’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Equinox Patents

Equinox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3115926-A1 Apparatus and methods to treat headaches Inactive 10-Oct-2018
JP-2021532920-A Devices and methods for regulating ocular blood flow Active 09-Aug-2018
JP-2021528185-A Eye treatment devices and methods using independent pressure sources Active 28-Jun-2018
JP-6926161-B2 Therapeutic treatment of the eye with gas Active 09-Mar-2016
JP-6581317-B2 Therapeutic treatment of the eye with gas Active 09-Mar-2016 A61H35/02
To view Equinox’s complete patent history, request access »

Equinox Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Equinox Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flying L Partners Venture Capital Minority
Visionary Venture Fund Venture Capital Minority
Bluestem Capital Company PE/Buyout Minority
National Space Biology Research Institute Corporation
To view Equinox’s complete investors history, request access »

Equinox FAQs

  • When was Equinox founded?

    Equinox was founded in 2014.

  • Where is Equinox headquartered?

    Equinox is headquartered in Newport Beach, CA.

  • What is the size of Equinox?

    Equinox has 36 total employees.

  • What industry is Equinox in?

    Equinox’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Equinox a private or public company?

    Equinox is a Private company.

  • What is Equinox’s current revenue?

    The current revenue for Equinox is .

  • How much funding has Equinox raised over time?

    Equinox has raised $36M.

  • Who are Equinox’s investors?

    Flying L Partners, Visionary Venture Fund, Bluestem Capital Company, and National Space Biology Research Institute have invested in Equinox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »